240 related articles for article (PubMed ID: 2184510)
21. [Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility of yeasts].
Wildfeuer A; Laufen H; Schmalreck AF; Yeates RA; Zimmermann T
Mycoses; 1996; 39 Suppl 2():51-7. PubMed ID: 9198746
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and tolerance of fluconazole suppositories in healthy volunteers.
Pfaff G; Zimmermann T; Lach P; Yeates R; Simon G; Wildfeuer A
Arzneimittelforschung; 1993 Mar; 43(3):391-5. PubMed ID: 8489572
[TBL] [Abstract][Full Text] [Related]
23. Bioavailability of fluconazole in surgical intensive care unit patients: a study comparing routes of administration.
Rosemurgy AS; Markowsky S; Goode SE; Plastino K; Kearney RE
J Trauma; 1995 Sep; 39(3):445-7. PubMed ID: 7473906
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysis.
Debruyne D; Ryckelynck JP; Moulin M; Hurault de Ligny B; Levaltier B; Bigot MC
Clin Pharmacokinet; 1990 Jun; 18(6):491-8. PubMed ID: 2354592
[TBL] [Abstract][Full Text] [Related]
25. Ocular uptake of fluconazole following oral administration.
O'Day DM; Foulds G; Williams TE; Robinson RD; Allen RH; Head WS
Arch Ophthalmol; 1990 Jul; 108(7):1006-8. PubMed ID: 2369337
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of fluconazole after oral administration of single and multiple doses in African grey parrots.
Flammer K; Papich M
Am J Vet Res; 2006 Mar; 67(3):417-22. PubMed ID: 16506902
[TBL] [Abstract][Full Text] [Related]
27. Absolute bioavailability, pharmacokinetics, and urinary excretion of the novel antimigraine agent almotriptan in healthy male volunteers.
Jansat JM; Costa J; Salvà P; Fernandez FJ; Martinez-Tobed A
J Clin Pharmacol; 2002 Dec; 42(12):1303-10. PubMed ID: 12463724
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of acyclovir after intravenous and oral administration.
de Miranda P; Blum MR
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():29-37. PubMed ID: 6355048
[TBL] [Abstract][Full Text] [Related]
29. [Clinical pharmacokinetics of azithromycin].
Singlas E
Pathol Biol (Paris); 1995 Jun; 43(6):505-11. PubMed ID: 8539072
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and bioavailability of fluconazole in patients with AIDS.
DeMuria D; Forrest A; Rich J; Scavone JM; Cohen LG; Kazanjian PH
Antimicrob Agents Chemother; 1993 Oct; 37(10):2187-92. PubMed ID: 8257143
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol.
Gross AS; McLachlan AJ; Minns I; Beal JB; Tett SE
Br J Clin Pharmacol; 2001 Jun; 51(6):547-55. PubMed ID: 11422014
[TBL] [Abstract][Full Text] [Related]
32. Safety and pharmacokinetics of fluconazole in children with neoplastic diseases.
Lee JW; Seibel NL; Amantea M; Whitcomb P; Pizzo PA; Walsh TJ
J Pediatr; 1992 Jun; 120(6):987-93. PubMed ID: 1593362
[TBL] [Abstract][Full Text] [Related]
33. The bioavailability and pharmacokinetics of guanfacine after oral and intravenous administration to healthy volunteers.
Carchman SH; Crowe JT; Wright GJ
J Clin Pharmacol; 1987 Oct; 27(10):762-7. PubMed ID: 3323255
[TBL] [Abstract][Full Text] [Related]
34. The clinical pharmacokinetics of levofloxacin.
Fish DN; Chow AT
Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of fluconazole in saliva and plasma after administration of an oral suspension and capsules.
Koks CH; Meenhorst PL; Hillebrand MJ; Bult A; Beijnen JH
Antimicrob Agents Chemother; 1996 Aug; 40(8):1935-7. PubMed ID: 8843308
[TBL] [Abstract][Full Text] [Related]
36. The effects of renal impairment on the pharmacokinetics and safety of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole.
Sobue S; Tan K; Layton G; Leclerc V; Weil A
Br J Clin Pharmacol; 2004 Jun; 57(6):773-84. PubMed ID: 15151523
[TBL] [Abstract][Full Text] [Related]
37. Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease.
Bramer SL; Forbes WP; Mallikaarjun S
Clin Pharmacokinet; 1999; 37 Suppl 2():1-11. PubMed ID: 10702882
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of fluconazole in skin and nails.
Faergemann J
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 2):S14-20. PubMed ID: 10367911
[TBL] [Abstract][Full Text] [Related]
39. Single dose intravenous pharmacokinetics of fluconazole in infants.
Krzeska I; Yeates RA; Pfaff G
Drugs Exp Clin Res; 1993; 19(6):267-71. PubMed ID: 8013270
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentrations in cerebrospinal fluid.
Madu A; Cioffe C; Mian U; Burroughs M; Tuomanen E; Mayers M; Schwartz E; Miller M
Antimicrob Agents Chemother; 1994 Sep; 38(9):2111-5. PubMed ID: 7811028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
